Skip to main content

Research Repository

Advanced Search

COSMIC, chemotherapy plus ofatumumab at standard or mega-dose in chronic lymphocytic leukaemia, a phase II randomised study

Allsup, David; Howard, Dena; Emmerson, Jake; Hockaday, Anna; Rawstron, Andy; Oughton, Jamie B.; Bloor, Adrian; Phillips, David; Nathwani, Amit; Paneesha, Shankara; Turner, Deborah; Munir, Talha; Hillmen, Peter

Authors

Profile Image

Dr David Allsup D.J.Allsup@hull.ac.uk
Senior Lecturer in Haematology and Honorary Consultant

Dena Howard

Jake Emmerson

Anna Hockaday

Andy Rawstron

Jamie B. Oughton

Adrian Bloor

David Phillips

Amit Nathwani

Shankara Paneesha

Deborah Turner

Talha Munir

Peter Hillmen



Citation

Allsup, D., Howard, D., Emmerson, J., Hockaday, A., Rawstron, A., Oughton, J. B., …Hillmen, P. (in press). COSMIC, chemotherapy plus ofatumumab at standard or mega-dose in chronic lymphocytic leukaemia, a phase II randomised study. British journal of haematology, https://doi.org/10.1111/bjh.17526

Journal Article Type Article
Acceptance Date Mar 12, 2021
Online Publication Date May 24, 2021
Deposit Date May 24, 2021
Publicly Available Date May 25, 2022
Journal British Journal of Haematology
Print ISSN 0007-1048
Electronic ISSN 1365-2141
Publisher Wiley
Peer Reviewed Peer Reviewed
DOI https://doi.org/10.1111/bjh.17526
Keywords Chronic lymphocytic leukaemia; Chemotherapy; Clinical trial; Monoclonal antibody; Minimal residual disease
Public URL https://hull-repository.worktribe.com/output/3773457

Files


Article (203 Kb)
PDF

Copyright Statement
©2021 The authors. All rights reserved. No part of this publication may be reproduced without the written permission of the copyright holder





You might also like



Downloadable Citations